Neal Shore, MD, FACS: Relugolix Approval for Advanced Prostate Cancer
Interview with Neal Shore, MD, FACS, about the approval of Relugolix for advanced prostate cancer and the significance of the treatment.
Our Affiliates
Dr. Shore’s article chosen as a NEJM “Most Notable Articles of 2020”
Leave a Reply
Want to join the discussion?Feel free to contribute!